Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome
A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.
Source: news-medical.net